Log In
BCIQ
Print this Print this
 

HT61

  Manage Alerts
Collapse Summary General Information
Company Helperby Therapeutics Group plc
DescriptionTopical antibiotic resistance breaker
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationStaphylococcus
Indication DetailsTreat methicillin-resistant Staphylococcus aureus (MRSA); Treat nasal carriage of Staphylococcus aureus prior to hospitalization
Regulatory Designation
PartnerCadila Pharmaceuticals Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/18/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today